John Nosenzo - Net Worth and Insider Trading

John Nosenzo Net Worth

The estimated net worth of John Nosenzo is at least $346,849 dollars as of 2024-04-28. John Nosenzo is the Fmr. Chief Commercial Officer of Bioventus Inc and owns about 87,148 shares of Bioventus Inc (BVS) stock worth over $346,849. Details can be seen in John Nosenzo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Nosenzo has not made any transactions after 2022-10-03 and currently still holds the listed stock(s).

Transaction Summary of John Nosenzo

To

John Nosenzo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Nosenzo owns 2 companies in total, including TELA Bio Inc (TELA) , and Bioventus Inc (BVS) .

Click here to see the complete history of John Nosenzo’s form 4 insider trades.

Insider Ownership Summary of John Nosenzo

Ticker Comapny Transaction Date Type of Owner
TELA TELA Bio Inc 2022-06-01 director
BVS Bioventus Inc 2022-10-03 Chief Commercial Officer

John Nosenzo Latest Holdings Summary

John Nosenzo currently owns a total of 1 stock. John Nosenzo owns 87,148 shares of Bioventus Inc (BVS) as of October 3, 2022, with a value of $346,849.

Latest Holdings of John Nosenzo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BVS Bioventus Inc 2022-10-03 87,148 3.98 346,849

Holding Weightings of John Nosenzo


John Nosenzo Form 4 Trading Tracker

According to the SEC Form 4 filings, John Nosenzo has made a total of 3 transactions in Bioventus Inc (BVS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Bioventus Inc is the sale of 142 shares on October 3, 2022, which brought John Nosenzo around $1,251.

Insider Trading History of John Nosenzo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Nosenzo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Nosenzo Ownership Network

Ownership Network List of John Nosenzo

No Data

Ownership Network Relation of John Nosenzo


John Nosenzo Owned Company Details

What does TELA Bio Inc do?

Who are the key executives at TELA Bio Inc?

John Nosenzo is the director of TELA Bio Inc. Other key executives at TELA Bio Inc include Chief Business Officer Gregory A. Firestone , COO and CFO Roberto Cuca , and director & Chief Executive Officer Antony Koblish .

TELA Bio Inc (TELA) Insider Trades Summary

Over the past 18 months, John Nosenzo made no insider transaction in TELA Bio Inc (TELA). Other recent insider transactions involving TELA Bio Inc (TELA) include a net sale of 192,000 shares made by Orbimed Advisors Llc , a net purchase of 20,262 shares made by Opaleye Management Inc. , and a net purchase of 11,000 shares made by Antony Koblish .

In summary, during the past 3 months, insiders sold 0 shares of TELA Bio Inc (TELA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 192,000 shares of TELA Bio Inc (TELA) were sold and 43,862 shares were bought by its insiders, resulting in a net sale of 148,138 shares.

TELA Bio Inc (TELA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TELA Bio Inc Insider Transactions

No Available Data

John Nosenzo Mailing Address

Above is the net worth, insider trading, and ownership report for John Nosenzo. You might contact John Nosenzo via mailing address: C/o Bioventus Inc., 4721 Emperor Boulevard, Suite 400, Durham Nc 27703.

Discussions on John Nosenzo

No discussions yet.